🇺🇸 FDA
Patent

US 8410292

Epoxy-guaiane derivatives and treatment of cancer

granted A61PA61P35/00A61P35/02

Quick answer

US patent 8410292 (Epoxy-guaiane derivatives and treatment of cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61P, A61P35/00, A61P35/02, A61P35/04